Description
Eprinomectinisasemi-syntheticavermectinthatisclinicallyusedtotreatlivestockanddomesticanimals;itexhibitsanti-helminthicandanti-parasiticactivities.EprinomectinincreasesGABArelease,causingneuromuscularparalysisinmicrobesandparasites.
Eprinomectinisasemi-syntheticavermectinthatisclinicallyusedtotreatlivestockanddomesticanimals;itexhibitsanti-helminthicandanti-parasiticactivities.EprinomectinincreasesGABArelease,causingneuromuscularparalysisinmicrobesandparasites.
| CasNo. | 123997-26-2 |
|---|---|
| Purity | ≥45% |
| Formula | B1a:C50H75NO14;B1b:C49H73NO14 |
| ChemicalName | (4""R)-4""-(Acetylamino)-4""-deoxy-avermectinB1 |
| Synonym | Eprinex |
| MeltingPoint | 163.3-165.7°C |
| Solubility | Solubleinmethanol. |
| Appearance | WhiteCrystallinePowder |
| StoreTemp | Ambient |
|---|---|
| ShipTemp | Ambient |
| MSDS | E6470MSDSPDF |
|---|---|
| InfoSheet | E6470InfoSheetPDF |
KnausM,ChesterST,RosentelJ,etal.Efficacyofanoveltopicalcombinationoffipronil,(S)-methoprene,eprinomectinandpraziquantelagainstlarvalandadultstagesofthecatlungworm,Aelurostrongylusabstrusus.VetParasitol.2014Apr28;202(1-2):64-8.PMID:24703080.
NazirT,KatochR,GodaraR,etal.Efficacyofeprinomectinpour-onagainstRhipicephalus(Boophilus)microplusonbuffaloes.JParasitDis.2013Oct;37(2):166-7.PMID:24431562.